Oak Hill Capital, a New York-based middle-market private equity firm, has partnered with Dan Renick to form Petauri Health, a pharmaceutical commercialization service.

Petauri Health, also based in New York, will look to acquire and combine companies with experience in global market access, medical affairs, patient services and data and analytics. The resulting Petuari platform will work to support clients with services that drive patient access to care. Oak Hill aims to deploy over $250 million of equity capital from its latest fund, OHCP VI, behind this initiative over time.

“The timing to form Petauri Health alongside Oak Hill could not be more critical as the remarkable pace of innovation continues to strain global healthcare budgets, resulting in unfulfilled benefits for patients with pressing medical needs,” states Renick, CEO. “Once assembled, Petauri’s diverse and accomplished industry experts will partner with clients across numerous commercialization domains to overcome marketplace barriers and speed access to medical advances.”